Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University, New South Wales, Australia.
NSW Health Pathology, Chatswood, New South Wales, Australia.
Ann Emerg Med. 2021 Jul;78(1):163-173. doi: 10.1016/j.annemergmed.2021.01.006. Epub 2021 Apr 9.
Laboratory test use varies across emergency departments (EDs), yet little is known about the effect of this variation on outcomes. The aim of this study is 2-fold: to stratify EDs into clusters based on similar test use, and to determine whether the clusters differ in patient operational outcomes among patients presenting to EDs with undifferentiated chest pain.
We conducted a retrospective cohort study of 222,788 patients presenting with undifferentiated chest pain at 44 EDs across New South Wales, Australia, from January 2017 to September 2018. The operational outcomes measured in this study included ED length of stay, hospital admission, the Emergency Treatment Performance target, and 7- and 15-day all-cause and same-cause ED revisit rates. We performed a hierarchic cluster analysis to identify ED clusters and mixed-effects models to determine the association between the clusters and the operational outcomes.
Two ED clusters, moderate users (18 EDs) and high users (26 EDs), were identified. After adjustment for confounders, the median ED length of stay was greater by 15.7% (equivalent to 33.4 minutes) in high versus moderate users (95% confidence interval 6.62 to 25.52 minutes), and high users were less likely to achieve the Emergency Treatment Performance target versus moderate users (odds ratio 0.66; 95% confidence interval 0.50 to 0.86). There were no significant differences between the users in hospital admission and ED revisit rates.
Our findings suggest that reducing test use may reduce ED length of stay and improve the chance of achieving the Emergency Treatment Performance target.
实验室检测在各急诊科(ED)的使用情况存在差异,但对于这种差异对结果的影响知之甚少。本研究旨在实现两个目标:根据相似的检测使用情况对 ED 进行分层聚类,并确定在以非特异性胸痛就诊的患者中,这些聚类在患者操作结局方面是否存在差异。
我们对 2017 年 1 月至 2018 年 9 月期间在澳大利亚新南威尔士州 44 家急诊科就诊的 222788 例非特异性胸痛患者进行了回顾性队列研究。本研究中测量的操作结局包括 ED 住院时间、住院、紧急治疗表现目标以及 7 天和 15 天全因和同因 ED 再就诊率。我们进行了层次聚类分析以确定 ED 聚类,并采用混合效应模型确定聚类与操作结局之间的关联。
确定了两个 ED 聚类,即中度使用者(18 个 ED)和高度使用者(26 个 ED)。在调整混杂因素后,与中度使用者相比,高度使用者的 ED 住院时间中位数长 15.7%(相当于 33.4 分钟)(95%置信区间 6.62 至 25.52 分钟),并且高度使用者实现紧急治疗表现目标的可能性低于中度使用者(比值比 0.66;95%置信区间 0.50 至 0.86)。在住院和 ED 再就诊率方面,两组使用者之间没有显著差异。
我们的研究结果表明,减少检测使用可能会缩短 ED 住院时间并提高实现紧急治疗表现目标的机会。